Circulating stem/progenitor cell biomarkers and prognosis in critically ill patients with gastrointestinal bleeding

doi:10.4252/wjsc.119749

Advanced Search

BPG is committed to discovery and dissemination of knowledge

Home / Archive / Volume 18, Issue 7

This Article

(18)

(19)

(0)

(172)

Peer-Review Report of This Article

CrossCheck and Google Search of This Article

Academic Rules and Norms of This Article

Citation of this article

Corresponding Author of This Article

Research Domain of This Article

Article-Type of This Article

Open-Access Policy of This Article

Times Cited Counts in Google of This Article

Journal Information of This Article

Publication Name

World Journal of Stem Cells

ISSN

1948-0210

Publisher of This Article

Baishideng Publishing Group Inc, 7041 Koll Center Parkway, Suite 160, Pleasanton, CA 94566, USA

Retrospective Study

Copyright: ©Author(s) 2026. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution-NonCommercial (CC BY-NC 4.0) license. No commercial re-use. See permissions. Published by Baishideng Publishing Group Inc.

World J Stem Cells. Jul 26, 2026; 18(7): 119749
Published online Jul 26, 2026. doi: 10.4252/wjsc.119749

Table 3 Comparison of outcomes and critical treatment measures, n (%)

Outcome/measures	Survival group (n = 111)	Death group (n = 29)	Statistical values	P value
7-day rebleeding rate	24 (21.62)	5 (17.24)	χ² = 0.269	0.604
Infusion RBC (U)	5.00 (3.00, 6.00)	5.00 (4.00, 7.00)	Z = -0.501	0.616
Vasoactive drug utilization	46 (41.44)	21 (72.41)	χ² = 8.839	0.003
Mechanical ventilation rate	36 (32.43)	19 (65.52)	χ² = 10.552	0.001
CRRT rate	28 (25.23)	9 (31.03)	χ² = 0.155	0.693
ICU stay (day)	6.00 (4.00, 9.00)	8.00 (5.00, 12.00)	Z = 1.556	0.031
Total hospitalization days	15.68 (12.80, 19.30)	14.82 (13.86, 20.32)	Z = -0.583	0.561
90-day mortality	31 (27.93)	12 (41.38)	χ² = 1.732	0.241

RBC: Red blood cell; CRRT: Continuous renal replacement therapy; ICU: Intensive care unit.

Full Size Table

Citation: Xie B, Zhang J, Wen YH, Zhao HF. Circulating stem/progenitor cell biomarkers and prognosis in critically ill patients with gastrointestinal bleeding. World J Stem Cells 2026; 18(7): 119749
URL: https://www.wjgnet.com/1948-0210/full/v18/i7/119749.htm
DOI: https://dx.doi.org/10.4252/wjsc.119749

Xie B, Zhang J, Wen YH, Zhao HF. Circulating stem/progenitor cell biomarkers and prognosis in critically ill patients with gastrointestinal bleeding. World J Stem Cells 2026; 18(7): 119749 [DOI: 10.4252/wjsc.119749]

All content on this site: Copyright © 1993-2026 Baishideng Publishing Group Inc, its licensors, and contributors. All rights are reserved, including those for text and data mining, AI training, and similar technologies. For all open access content, the relevant licensing terms apply.